...
首页> 外文期刊>Bulletin of the Korean Chemical Society >Theoretical Characterization of Binding Mode of Organosilicon Inhibitor with p38: Docking, MD Simulation and MM/GBSA Free Energy Approach
【24h】

Theoretical Characterization of Binding Mode of Organosilicon Inhibitor with p38: Docking, MD Simulation and MM/GBSA Free Energy Approach

机译:p38对有机硅抑制剂结合模式的理论表征:对接,MD模拟和MM / GBSA自由能方法

获取原文

摘要

P38 mitogen activated protein (MAP) kinase is an important anti-inflammatory drug target, which can be activated by responding to various stimuli such as stress and immune response. Based on the conformation of the conserved DFG loop (in or out), binding inhibitors are termed as type-I and II. Type-I inhibitors are ATP competitive, whereas type-II inhibitors bind in DFG-out conformation of allosteric pocket. It remains unclear that how these allosteric inhibitors stabilize the DFG-out conformation and interact. Organosilicon compounds provide unusual opportunity to enhance potency and diversity of drug molecules due to their low toxicity. However, very few examples have been reported to utilize this property. In this regard, we performed docking of an inhibitor (BIRB) and its silicon analog (Si-BIRB) in an allosteric binding pocket of p38. Further, molecular dynamics (MD) simulations were performed to study the dynamic behavior of the simulated complexes. The difference in the biological activity and mechanism of action of the simulated inhibitors could be explained based on the molecular mechanics/generalized Born surface area (MM/GBSA) binding free energy per residue decomposition. MM/GBSA showed that biological activities were related with calculated binding free energy of inhibitors. Analyses of the per-residue decomposed energy indicated that van der Waals and non-polar interactions were predominant in the ligand-protein interactions. Further, crucial residues identified for hydrogen bond, salt bridge and hydrophobic interactions were Tyr35, Lys53, Glu71, Leu74, Leu75, Ile84, Met109, Leu167, Asp168 and Phe169. Our results indicate that stronger hydrophobic interaction of Si-BIRB with the binding site residues could be responsible for its greater binding affinity compared with BIRB.
机译:P38丝裂原活化蛋白(MAP)激酶是重要的抗炎药物靶标,可以通过响应各种刺激(例如压力和免疫应答)来激活。基于保守的DFG环的构象(入或出),结合抑制剂被称为I型和II型。 I型抑制剂具有ATP竞争性,而II型抑制剂则结合变构口袋的DFG-out构象。尚不清楚这些变构抑制剂如何稳定DFG-out构象并相互作用。有机硅化合物因其低毒性而提供了提高药物分子效价和多样性的难得机会。但是,据报道很少有利用该特性的例子。在这方面,我们将抑制剂(BIRB)及其硅类似物(Si-BIRB)对接在p38的变构结合口袋中。此外,进行了分子动力学(MD)模拟以研究模拟复合物的动力学行为。模拟抑制剂的生物活性和作用机理的差异可以基于分子动力学/每个残基分解的结合自由能的广义玻恩表面积(MM / GBSA)来解释。 MM / GBSA表明,生物活性与抑制剂的计算结合自由能有关。对每个残基分解能的分析表明,范德华和非极性相互作用在配体-蛋白质相互作用中占主导地位。此外,鉴定为氢键,盐桥和疏水相互作用的关键残基为Tyr35,Lys53,Glu71,Leu74,Leu75,Ile84,Met109,Leu167,Asp168和Phe169。我们的结果表明,与BIRB相比,Si-BIRB与结合位点残基之间更强的疏水性相互作用可能是其更大的结合亲和力的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号